At the time of writing, Qiagen NV [QGEN] stock is trading at $55.66, up 0.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The QGEN shares have gain 17.92% over the last week, with a monthly amount glided 23.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on December 11, 2025, when Citigroup downgraded its rating to a Neutral but kept the price target unchanged to $50 for it. Previously, Barclays started tracking the stock with Overweight rating on June 24, 2025, and set its price target to $55. On April 04, 2025, downgrade downgraded it’s rating to Neutral. Robert W. Baird downgraded its rating to a Neutral and decreased its price target to $42 on February 19, 2025. Morgan Stanley downgraded its rating to a Equal-Weight but $48 remained the price target by the analyst firm on January 06, 2025. Jefferies upgraded its rating to Buy for this stock on December 10, 2024, and upped its price target to $54. In a note dated October 17, 2024, HSBC Securities downgraded an Hold rating on this stock but restated the target price of $49.
For the past year, the stock price of Qiagen NV fluctuated between $37.59 and $57.81. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $55.66 at the most recent close of the market. An investor can expect a potential drop of -1.19% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
According to Qiagen NV [NYSE:QGEN], the company’s sales were 2.07B for trailing twelve months, which represents an 6.12% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.2%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.11 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Qiagen NV [NYSE:QGEN] has a current ratio of 2.60. Further, the Quick Ratio stands at 2.30, while the Cash Ratio is 1.39. Considering the valuation of this stock, the price to sales ratio is 5.56, the price to book ratio is 3.14 and price to earnings (TTM) ratio is 28.52.
Transactions by insiders
Recent insider trading involved Thierry Bernard, Officer, that happened on Aug 15 ’25 when 25000.0 shares were purchased. Officer, ROLAND SACKERS completed a deal on Aug 15 ’25 to buy 31423.0 shares. Meanwhile, Officer ROLAND SACKERS bought 18577.0 shares on Aug 14 ’25.
